Is a complete ETR/B8FK research report available?

No complete published report is available for etr/B8FK (ETR/B8FK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ETR/B8FK (ETR/B8FK)

Deutsche Börse Xetra: ETR/B8FK · EUR

€2.44

+0.00 (0.0%)· Recorded snapshot

Market cap	15.1M
Revenue (ttm)	13.6M
Net income (ttm)	-2.4M
EPS (ttm)	-€0.40
Shares out	6.1M
Volume	940
Beta	-0.23

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 13.6M
Net income (ttm): -2.4M
EPS (ttm): -€0.40
Market cap: 15.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-06 02:00 UTC

All ETR/B8FK indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

EUR

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	69
Employees Change	-18%
Employees Change Percent	-20.69
Enterprise value	EUR 11.3M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	27.1
Industry PE Fwd	16.59
Isin	DE000A4BGGM7
Last refreshed	2026-09-06
Market cap	EUR 15.1M
Price	EUR 2.44
Price currency	EUR
Rev Per Employee	197,521.74x
Sector	Healthcare
Sector PE	38.15
Sector PE Fwd	14.39
Sic	2834
Symbol	etr/B8FK
Website	https://www.biofrontera.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.21%
EV/Sales	0.83x
FCF yield	-29.53%
P/B ratio	0.88x
P/S ratio	1.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.88%
EBITDA Margin	-4.65%
Gross margin	82.41%
Gross Profit	EUR 11.2M
Gross Profit Growth	11.04%
Gross Profit Growth3 Y	-18.8%
Gross Profit Growth5 Y	-15.97%
Net Income	EUR -2.4M
Net Income Growth Years	0%
Pretax Margin	-7.01%
Profit Margin	-17.93%
Profit Per Employee	EUR -35,406
Profitable Quarters	EUR 2
ROA	-1.96
Roa5y	-1.9
ROCE	-4.39
ROE	-36.44
Roe5y	-9.05
ROIC	-6.49
Roic5y	-5.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-27.08%
Cagr15y	-17.44%
Cagr1y	-4.32%
Cagr3y	-42.14%
Cagr5y	-45.61%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	11.87x
Revenue Growth Q	13.44x
Revenue Growth Years	0x
Revenue Growth3 Y	-19.1x
Revenue Growth5 Y	-14.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.53
Assets	EUR 22.7M
Cash	EUR 5.6M
Current Assets	EUR 13.3M
Current Liabilities	EUR 4.5M
Debt	EUR 1.9M
Debt Equity	EUR 0.11
Debt FCF	EUR -0.42
Equity	EUR 17.1M
Interest Coverage	-42.21
Liabilities	EUR 5.6M
Long Term Assets	EUR 9.5M
Long Term Liabilities	EUR 1.2M
Net Cash	EUR 3.7M
Net Cash By Market Cap	EUR 24.87
Net Cash Growth	58.88%
Net Debt Equity	EUR -0.22
Tangible Book Value	EUR 17.1M
Tangible Book Value Per Share	EUR 2.81
WACC	2.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.96
Inventory Turnover	0.55
Net Working Capital	EUR 3.9M
Quick ratio	2.07
Working Capital	EUR 8.8M
Working Capital Turnover	EUR 1.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-95.75%
1Y total return	-4.31%
200-day SMA	2.52
3Y total return	-80.63%
50-day SMA	2.45
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.24%
All Time High	341.3
All Time High Change	-99.28%
All Time High Date	2007-02-07
All Time Low	2.08
All Time Low Change	17.31%
All Time Low Date	2024-12-30
ATR	0.12
Beta	-0.23
Beta1y	0.29
Beta2y	0.08
High	2.55
High52	2.96
High52 Date	2025-11-04
High52ch	-17.57%
Low	2.33
Low52	2.21
Low52 Date	2026-06-29
Low52ch	10.41%
Ma50ch	-0.2%
Price vs 200-day SMA	-3.02%
RSI	51.63
RSI Monthly	28.88
RSI Weekly	49.5
Sharpe ratio	-0.02x
Sharpe Ratio3y	-0.66x
Sharpe Ratio5y	-0.81x
Sortino ratio	0.14
Sortino Ratio3y	-0.8
Sortino Ratio5y	-1.02
Total Return	0.22%
Tr15y	-94.36%
Tr1m	-5.06%
Tr3m	-7.92%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,397,458%
Net Borrowing	-438,000
Shares Out	6,076,862
Shares Yo Y	-0.22%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	654.2x
Bv Per Share	2.81
CAPEX	EUR -51,000
Ch10y	-96.24
Ch15y	-95.44
Ch1m	-5.06
Ch1y	-4.31
Ch3m	-7.92
Ch3y	-80.63
Ch5y	-95.44
Ch6m	-9.29
Change	0%
Change From Open	4.72
Close	2.44
Days Gap	-4.51
Depreciation Amortization	168,250
Dollar Volume	2,293.6
Earnings Date	2026-09-30
EBIT	EUR -802,000
EBITDA	EUR -633,750
EPS	EUR -0.4
F Score	2
FCF	EUR -4.5M
FCF EV Yield	-39.31x
FCF Per Share	EUR -0.73
Financing CF	-452,000
Fiscal Year End	December
Founded	1,997
Income Tax	EUR 5.7M
Investing CF	5,331,000
Is Primary Listing	1
Last Earnings Date	2026-05-31
Last Report Date	2026-03-31
Last Split Date	2024-05-14
Last Split Type	Reverse
Ma150	2.5
Ma150ch	-2.2%
Ma20	2.46
Ma20ch	-0.77%
Net CF	479,000
Next Earnings Date	2026-09-30
Open	2.33
Position In Range	50
Ppne	2,047,000
Price Date	2026-09-04
Ptbv Ratio	0.88
Relative Volume	1.43x
Revenue	13,629,000x
Tax By Revenue	41.98x
Tr6m	-9.29%
Volume	940
Z Score	-5.17

ETR/B8FK (ETR/B8FK)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/B8FK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/B8FK indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ETR/B8FK

Frequently asked questions